Heroin neuroteratogenicity: Delayed-onset deficits in catecholaminergic synaptic activity

Brain Research

Volumn 984, Issue 1-2, 2003, Pages 189-197

  Slotkin, Theodore A ^a   Seidler, Frederic J ^a   Yanai, Joseph ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

Dopamine; Heroin; Neuroteratogenesis; Norepinephrine; Opiate

Indexed keywords

CATECHOLAMINE; DIAMORPHINE; DOPAMINE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; HIPPOCAMPUS; MALE; MOUSE; NEUROTOXICITY; NEWBORN; NONHUMAN; NORADRENERGIC SYSTEM; PERINATAL PERIOD; PRENATAL EXPOSURE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNAPSE; TERATOGENICITY;

EID: 0043158687     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)03152-4     Document Type: Article

References (31)

1. Barron S., Kelly S.J., Riley E.P. Neonatal alcohol exposure alters suckling performance in rat pups. Pharmacol. Biochem. Behav. 39:1991;423-427.
2. Behnke M., Eyler F.D. The consequences of prenatal substance use for the developing fetus, newborn, and young child. Int. J. Addict. 28:1993;1341-1391.
3. Dam K., Garcia S.J., Seidler F.J., Slotkin T.A. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Dev. Brain Res. 116:1999;9-20.
4. Fernandez K., Caul W.F., Haenlein M., Vorhees C.V. Effects of prenatal alcohol on homing behavior, maternal responding and open-field activity in rats. Neurobehav. Toxicol. Teratol. 5:1983;351-356.
5. Garcia S.J., Seidler F.J., Crumpton T.L., Slotkin T.A. Does the developmental neurotoxicity of chlorpyrifos involve glial targets? Macromolecule synthesis, adenylyl cyclase signaling, nuclear transcription factors, and formation of reactive oxygen in C6 glioma cells. Brain Res. 891:2001;54-68.
6. Lichtblau L., Sparber S.B. Opioids and development: a perspective on experimental models and methods. Neurobehav. Toxicol. Teratol. 6:1984;3-8.
7. 3H]dihydromorphine binding sites within the hippocampus of the rat. Eur. J. Pharmacol. 68:1980;175-179.
8. Seidler F.J., Albright E.S., Lappi S.E., Slotkin T.A. In search of a mechanism for receptor-mediated neurobehavioral teratogenesis by nicotine: catecholamine release by nicotine in immature rat brain regions. Dev. Brain Res. 82:1994;1-8.
9. Seidler F.J., Levin E.D., Lappi S.E., Slotkin T.A. Fetal nicotine exposure ablates the ability of postnatal nicotine challenge to release norepinephrine from rat brain regions. Dev. Brain Res. 69:1992;288-291.
10. Seidler F.J., Slotkin T.A. Effects of acute hypoxia on neonatal rat brain: regionally selective, long-term alterations in catecholamine levels and turnover. Brain Res. Bull. 24:1990;157-161.
11. Seidler F.J., Temple S.W., McCook E.C., Slotkin T.A. Cocaine inhibits central noradrenergic and dopaminergic activity during the critical developmental period in which catecholamines influence cell development. Dev. Brain Res. 85:1995;48-53.
12. Shahak H., Slotkin T.A., Yanai J. Alterations in PKCγ in the mouse hippocampus after prenatal exposure to heroin: a link from cell signaling to behavioral outcome. Dev. Brain Res. 140:2003;117-125.
13. Slotkin T.A. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ. Health Perspect. 107:(Suppl. 1):1999;71-80.
14. Slotkin T.A., Epps T.A., Stenger M.L., Sawyer K.J., Seidler F.J. Cholinergic receptors in heart and brainstem of rats exposed to nicotine during development: implications for hypoxia tolerance and perinatal mortality. Dev. Brain Res. 113:1999;1-12.
15. Slotkin T.A., McCook E.C., Lappi S.E., Seidler F.J. Altered development of basal and forskolin-stimulated adenylate cyclase activity in brain regions of rats exposed to nicotine prenatally. Dev. Brain Res. 68:1992;233-239.
16. Slotkin T.A., Pinkerton K.E., Garofolo M.C., Auman J.T., McCook E.C., Seidler F.J. Perinatal exposure to environmental tobacco smoke induces adenylyl cyclase and alters receptor-mediated signaling in brain and heart of neonatal rats. Brain Res. 898:2001;73-81.
17. Slotkin T.A., Seidler F.J., Yanai J. Heroin neuroteratogenicity: targeting adenylyl cyclase as an underlying biochemical mechanism. Dev. Brain Res. 132:2001;75-85.
18. Slotkin T.A., Weigel S.J., Barnes G.A., Whitmore W.L., Seidler F.J. Alterations in the development of catecholamine turnover induced by perinatal methadone: differences in central vs. peripheral sympathetic nervous systems. Life Sci. 29:1981;2519-2525.
19. Slotkin T.A., Whitmore W.L., Salvaggio M., Seidler F.J. Perinatal methadone addiction affects brain synaptic development of biogenic amine systems in the rat. Life Sci. 24:1979;1223-1230.
20. Snedecor G.W., Cochran W.G. Statistical Methods. 1967;Iowa State University Press, Ames, IA.
21. Song X., Seidler F.J., Saleh J.L., Zhang J., Padilla S., Slotkin T.A. Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol. Appl. Pharmacol. 145:1997;158-174.
22. Steingart R.A., Abou-Roumi M., Newman M.E., Silverman W.F., Slotkin T.A., Yanai J. Neurobehavioral damage to cholinergic systems caused by prenatal exposure to heroin or phenobarbital: cellular mechanisms and the reversal of deficits by neural grafting. Dev. Brain Res. 122:2000;125-133.
23. Steingart R.A., Barg J., Maslaton J., Nesher M., Yanai J. Pre- and postsynaptic alterations in the septohippocampal cholinergic innervations after prenatal exposure to drugs. Brain Res. Bull. 46:1998;203-209.
24. Steingart R.A., Silverman W.F., Barron S., Slotkin T.A., Awad Y., Yanai J. Neural grafting reverses prenatal drug-induced alterations in hippocampal PKC and related behavioral deficits. Dev. Brain Res. 125:2000;9-19.
25. Yanai J., Avraham Y., Levy S., Maslton J., Pick C.G., Rogel-Fuchs Y., Zahalka E.A. Alterations in septohippocampal cholinergic innervation and related behavior after early exposure to heroin and phencyclidine. Dev. Brain Res. 69:1992;207-214.
26. Yanai J., Rogel-Fuchs Y., Pick C.G., Slotkin T., Seidler F.J., Zahalka E.A., Newman M.E. Septohippocampal cholinergic changes after destruction of the AlO-septal dopaminergic pathways. Neuropharmacology. 32:1993;113-117.
27. Yanai J., Vatury O., Slotkin T.A. Cell signaling as a target and underlying mechanism for neurobehavioral teratogenesis. Ann. NY Acad. Sci. 965:2002;473-478.
28. Zagon I.S., McLaughlin P.J. Maternal exposure to opioids and the developing nervous system: laboratory findings. Zagon I.S., Slotkin T.A. Maternal Substance Abuse and the Developing Nervous System. 1992;241-282 Academic Press, San Diego.
29. Zagon I.S., McLaughlin P.J., Weaver D.J., Zagon E. Opiates, endorphins and the developing organism: a comprehensive bibliography. Neurosci. Biobehav. Rev. 6:1982;439-479.
30. Zagon I.S., McLaughlin P.J., Zagon E. Opiates, endorphins, and the developing organism: a comprehensive bibliography, 1982-1983. Neurosci. Biobehav. Rev. 8:1984;387-403.
31. Zhu J.H., Stadlin A. Prenatal heroin exposure. Effects on development, acoustic startle response, and locomotion in weanling rats. Neurotoxicol. Teratol. 22:2000;193-203.